Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease.

DeBusk RF, Pepine CJ, Glasser DB, Shpilsky A, DeRiesthal H, Sweeney M.

Am J Cardiol. 2004 Jan 15;93(2):147-53. Erratum in: Am J Cardiol. 2004 Aug 15;94(4):543-4.

PMID:
14715338
2.

Sildenafil for male erectile dysfunction: a systematic review and meta-analysis.

Fink HA, Mac Donald R, Rutks IR, Nelson DB, Wilt TJ.

Arch Intern Med. 2002 Jun 24;162(12):1349-60. Review.

PMID:
12076233
4.

Efficacy and safety of sildenafil citrate (Viagra) in men with erectile dysfunction and spinal cord injury: a review.

Derry F, Hultling C, Seftel AD, Sipski ML.

Urology. 2002 Sep;60(2 Suppl 2):49-57. Review.

PMID:
12414333
5.

Correlations between increased erection hardness and improvements in emotional well-being and satisfaction outcomes in men treated with sildenafil citrate for erectile dysfunction.

King R, Juenemann KP, Levinson IP, Stecher VJ, Creanga DL.

Int J Impot Res. 2007 Jul-Aug;19(4):398-406. Epub 2007 Mar 15. Review.

PMID:
17361232
6.

Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up.

Raina R, Lakin MM, Agarwal A, Sharma R, Goyal KK, Montague DK, Klein E, Zippe CD.

Urology. 2003 Jul;62(1):110-5. Review.

PMID:
12837433
7.

Cardiovascular effects of sildenafil citrate and recommendations for its use.

Kloner RA, Zusman RM.

Am J Cardiol. 1999 Sep 9;84(5B):11N-17N. Review.

PMID:
10503571
8.

Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction.

Goldenberg MM.

Clin Ther. 1998 Nov-Dec;20(6):1033-48. Review.

PMID:
9916601
9.

New treatment options for erectile dysfunction in patients with diabetes mellitus.

Basu A, Ryder RE.

Drugs. 2004;64(23):2667-88. Review.

PMID:
15537369
10.

Overall cardiovascular profile of sildenafil citrate.

Zusman RM, Morales A, Glasser DB, Osterloh IH.

Am J Cardiol. 1999 Mar 4;83(5A):35C-44C. Review.

PMID:
10078541
11.

Sex and the patient with cardiovascular risk factors: focus on sildenafil.

Kloner RA.

Am J Med. 2000 Dec 18;109 Suppl 9A:13S-21S; discussion 29S-30S. Review.

PMID:
11137498
12.

[Sex, erectile dysfunction, and the heart: a growing problem].

Görge G, Flüchter S, Kirstein M, Kunz T.

Herz. 2003 Jun;28(4):284-90. Review. German.

PMID:
12825143
13.

Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.

Corbin JD, Francis SH, Webb DJ.

Urology. 2002 Sep;60(2 Suppl 2):4-11. Review.

PMID:
12414329
14.

Sildenafil in patients with cardiovascular disease.

Brindis RG, Kloner RA.

Am J Cardiol. 2003 Nov 6;92(9A):26M-36M. Review.

PMID:
14609621
15.

Sildenafil: a 4-year update in the treatment of 20 million erectile dysfunction patients.

Carson CC 3rd.

Curr Urol Rep. 2003 Dec;4(6):488-96. Review.

PMID:
14622503
16.

Cardiovascular risk and sildenafil.

Kloner RA.

Am J Cardiol. 2000 Jul 20;86(2A):57F-61F. Review.

PMID:
10899281
17.

PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.

Rosen RC, McKenna KE.

Annu Rev Sex Res. 2002;13:36-88. Review.

PMID:
12836729
18.
19.

[New principle in therapy of erectile dysfunction: sildenafil].

Weidmann P.

Ther Umsch. 1998 Jun;55(6):384-8. Review. German.

PMID:
9658982
20.

Sildenafil citrate: lessons learned from 3 years of clinical experience.

Hatzichristou DG.

Int J Impot Res. 2002 Feb;14 Suppl 1:S43-52. Review.

Supplemental Content

Support Center